Drug – bio-affecting and body treating compositions – Lymphokine
Reexamination Certificate
2003-05-01
2011-12-27
Ewoldt, Gerald R (Department: 1644)
Drug, bio-affecting and body treating compositions
Lymphokine
C424S085200, C424S130100, C424S133100, C424S141100, C424S143100, C424S152100, C424S156100
Reexamination Certificate
active
08084020
ABSTRACT:
The invention provides methods for the administration of an anti-CD 1 antibody for the treatment or prevention of a variety of disorders, such as autoimmune disease, viral infection, bacterial infection, parasitic infection, infection by a eukaryotic pathogen, allergy, asthma, inflammatory condition, graft versus host disease, graft rejection, immunodeficiency disease, spontaneous abortion, pregnancy, and cancer.
REFERENCES:
patent: 5679347 (1997-10-01), Porcelli et al.
patent: 5853737 (1998-12-01), Modlin et al.
patent: 6238676 (2001-05-01), Porcelli et al.
patent: 2001/0051156 (2001-12-01), Zeng et al.
patent: 2002/0094542 (2002-07-01), Leskovar
patent: 2002/0115624 (2002-08-01), Behar et al.
patent: 2006/0002927 (2006-01-01), Exley et al.
patent: 0 677 533 (1995-10-01), None
patent: 1 025 854 (2000-08-01), None
patent: WO 96/33730 (1996-10-01), None
patent: WO 99/34209 (1999-07-01), None
patent: WO 01/98357 (2001-12-01), None
Amano et al (J. Immunol. 1998, 161: 1710-1717).
Landes Bioscience: APC Dysfunction in SLE, http://www.ncbi.nlm.nih.gov/books/bv.fcgi?rid=eurekah.section.13810, 2008.
Zeng et al (J. Clin. Invest. Oct. 2003, 112(8): 1211-1222).
Rhee et al (FASEB J. Mar. 20, 2002, vol. 16, No. 5, pp. A1228).
Rhee et al (J. Surg. Res. 2003, 115(1): 74-81).
Fahey et al., Clinical Experimental Immunology, 1992, 88: 1-5.
Letvin, Science, 1998, 280: 1875-1880.
Machuca et al. Intervirology 1999, 42: 37-42.
Parker and Watkins (Brit. J. Surgery. 2001, 88: 22-30).
Schinkel (J. Interferon & Cytokine Research, 2003, 23: 341-349).
De St. Groth et al (Immunology and Cell Biology 2004, 82: 260-268).
Teng et al (Journal of Immunology, 2009, 182: 3366-3371).
Mocellin et al (J. Leuk. Biol. 2005, 78: 1043-1051).
Balk et al., “Isolation and Characterization of a cDNA and Gene Coding for a Fourth CD1 Molecule,”Proc. Natl. Acad. Sci. U.S.A.86:252-256 (1989).
Bendelac et al., “Mouse CD1-Specific NK1 T Cells: Development, Specificity, and Function,”Annu. Rev. Immunol.15:535-562 (1997).
Bender et al., “T Cell Receptor Repertoire in Polymyositis: Clonal Expansion of Autoaggressive CD8+T Cells,”J. Exp. Med.181:1863-1868 (1995).
Benlagha et al., “In Vivo Identification of Glycolipid Antigen-Specific T Cells Using Fluorescent CD1d Tetramers,”J. Exp. Med.191:1895-1903 (2000).
Bleicher et al., “Expression of Murine CD1 on Gastrointestinal Epithelium,”Science250:679-682 (1990).
U.S. Appl. No. 09/885,768, filed Jun. 19, 2001, Exley et al.
Blumberg et al., “Human Intestinal Intraepithelial Lymphocytes are Derived from a Limited Number of T Cell Clones that Utilize Multiple Vβ T Cell Receptor Genes,”J. Immunol.150:5144-5153 (1993).
Bubley and Balk, “Treatment of Metastatic Prostate Cancer. Lessons from the Androgen Receptor,”Hematol. Oncol. Clin. North Am.10:713-725 (1996).
Carnaud et al., “Cross-Talk Between Cells of the Innate Immune System: NKT Cells Rapidly Activate NK Cells,”J. Immunol.163:4647-4650 (1999).
Catalona, “Management of Cancer of the Prostate,”N. Engl. J. Med.331:996-1004 (1994).
Cho et al., “A Genome-Wide Transcriptional Analysis of the Mitotic Cell Cycle,”Mol. Cell2:65-73 (1998).
Chott et al., “A Common TCR β-Chain Expressed by CD8+Intestinal Mucosa T Cells in Ulcerative Colitis,”J. Immunol.156:3024-3035 (1996).
Colgan et al., “Ligation of Intestinal Epithelial CD1d Induces Bioactive IL-10: Critical Role of the Cytoplasmic Tail in Autocrine Signaling,”Proc. Natl. Acad. Sci. U.S.A.96: 13938-13943 (1999).
Cui et al., “Requirement for Vα 14 NKT Cells in IL-12-Mediated Rejection of Tumors,”Science278:1623-1626 (1997).
Dellabona et al., “An Invariant Vα24-JαQ/Vβ11 T Cell Receptor is Expressed in All Individuals by Clonally Expanded CD4−8−T Cells,”J. Exp. Med.180:1171-1176 (1994).
Dezutter-Dambuyant et al., “Cleavage of Langerhans Cell Surface CD1a Molecule by Trypsin,”Res. Immunol.140:377-390 (1989).
Exley et al., “Association of Phosphatidylinositol 3-Kinase with a Specific Sequence of the T Cell Receptor ζ Chain is Dependent on T Cell Activation,”J. Biol. Chem.269:15140-15146 (1994).
Exley et al., “Requirements for CD1d Recognition by Human Invariant Vα24+CD4−CD8−T Cells,”J. Exp. Med.186:109-120 (1997).
Exley et al., “CD161 (NKR-P1A) Costimulation of CD1d-Dependent Activation of Human T Cells Expressing Invariant Vα24JαQ T Cell Receptor α Chains,”J. Exp. Med.188:867-876 (1998).
Exley et al., “CD1d Structure and Regulation on Human Thymocytes, Peripheral Blood T Cells, B Cells and Monocytes,”Immunology100:37-47 (2000).
Exley et al., “A Major Fraction of Human Bone Marrow Lymphocytes are Th2-Like CD1d-Reactive T Cells that can Suppress Mixed Lymphocyte Responses,”J. Immunol.167:5531-5534 (2001).
Exley et al., “CD1d-Reactive T-Cell Activation Leads to Amelioration of Disease Caused by Diabetogenic Encephalomyocarditis Virus,”J. Leukoc. Biol.69:713-718 (2001).
Falcone et al., “A Defect in Interleukin 12-Induced Activation and Interferon γ Secretion of Peripheral Natural Killer T Cells in Nonobese Diabetic Mice Suggests New Pathogenic Mechanisms for Insulin-Dependent Diabetes Mellitus,”J. Exp. Med.190:963-972 (1999).
Farace et al., “T Cell Repertoire in Patients with B Chronic Lymphocytic Leukemia,”J. Immunol.153:4281-4290 (1994).
Fitzgerald et al., “Analysis of Clonal CD8+T Cell Expansions in Normal Individuals and Patients with Rheumatoid Arthritis,”J. Immunol.154:3538-3547 (1995).
Gavilondo et al., “Antibody Engineering at the Millennium,”Biotechniques29:128-145 (2000).
Giron et al., “Inhibition of Virus-Induced Diabetes Mellitus by Interferon is Influenced by the Host Strain,”Proc. Soc. Exp. Biol. Med.173:328-331 (1983).
Gorochov et al., “Oligoclonal Expansion of CD8+CD57+T Cells with Restricted T-Cell Receptor β Chain Variability After Bone Marrow Transplantation,”Blood83:587-595 (1994).
Grunewald et al., “CD+and CD8+T Cell Expansions Using Selected TCR V and J Gene Segments at the Onset of Giant Cell Arteritis,”Arthritis Rheum.37:1221-1227 (1994).
Hammerberg et al., “Reversal of Immunosuppression Inducible Through Ultraviolet-Exposed Skin by In Vivo Anti-CD11b Treatment,”J. Immunol.157:5254-5261 (1996).
Hingorani et al., “Oligoclonality of Vβ3 TCR Chains in the CD8+T Cell Population of Rheumatoid Arthritis Patients,”J. Immunol.156:852-858 (1996).
Hong and Van Kaer, “Immune Privilege: Keeping an Eye on Natural Killer T Cells,”J. Exp. Med.190:1197-1200 (1999).
Huber et al., “Vγ4+T Cells Promote Autoimmune CD8+Cytolytic T-Lymphocyte Activation in Coxsackievirus B3-Induced Myocarditis in Mice: Role for CD4+Th1 Cells,”J. Virol.76:10785-10790 (2002).
Illés et al., “Differential Expression of NK T Cell Vα24JαQ Invariant TCR Chain in the Lesions of Multiple Sclerosis and Chronic Inflammatory Demyelinating Polyneuropathy,”J. Immunol.164:4375-4381 (2000).
Ito et al., “Involvement of Decidual Vα14 NKT Cells in Abortion,”Proc. Natl. Acad. Sci. U.S.A.97:740-744 (2000).
Jameson et al., “The T Cell Receptor Vα11 Gene Family. Analysis of Allelic Sequence Polymorphism and Demonstration of Jα Region-Dependent Recognition by Allele-Specific Antibodies,”J. Immunol.147:3185-3193 (1991).
Johnson and Wu, “Kabat Database and its Applications: Future Directions,”Nucleic Acids Res.29:205-206 (2001).
Kahn-Perles et al., “Delineation of Three Subsets of Class I Human T Antigens (HTA) on Molt-4 Cells: Serologic and Regulatory Relationship to HLA Class I Antigens,”J. Immunol.134:1759-1765 (1985).
Karnbach et al., “Immune Rejection of a Large Sarco
Balk Steven P.
Exley Mark A.
Yue Simon C.
Beth Israel Deaconess Medical Center
Bieker-Brady Kristina
Clark & Elbing LLP
DiBrino Marianne
Ewoldt Gerald R
LandOfFree
Use of anti-CD1 antibodies for the modulation of immune... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of anti-CD1 antibodies for the modulation of immune..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of anti-CD1 antibodies for the modulation of immune... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4310377